CORT Q4 2023 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$135M+31.4% YoY

Gross Profit

$134M98.6% margin

Operating Income

$32M23.4% margin

Net Income

$31M23.2% margin

EPS (Diluted)

$0.28

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$622M

Total Liabilities

$115M

Stockholders' Equity

$507M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$135M	$103M	+31.4%
Gross Profit	$134M	$102M	+31.5%
Operating Income	$32M	$22M	+40.8%
Net Income	$31M	$17M	+88.9%